Angela O. Achieng

Temporal trends in prevalence of Plasmodium falciparum molecular markers selected for by artemether–lumefantrine treatment in pre-ACT and post-ACT parasites in western Kenya

Angela O. Achieng, Peninah Muiruri, Luicer A. Ingasia et al. · International Journal for Parasitology Drugs and Drug Resistance · 2015 · 61 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +13

Analysis of Major Genome Loci Underlying Artemisinin Resistance and pfmdr1 Copy Number in pre- and post-ACTs in Western Kenya

Bidii S. Ngalah, Luiser A. Ingasia, Agnes C. Cheruiyot et al. · Scientific Reports · 2015 · 32 citations · Full text

Veterinary Medicine, Infectious Diseases, Molecular Genetics +13

Fast-Acting Small Molecules Targeting Malarial Aspartyl Proteases, Plasmepsins, Inhibit Malaria Infection at Multiple Life Stages

Snigdha Singh, Vinoth Rajendran, Jiang He et al. · ACS Infectious Diseases · 2018 · 23 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Molecular basis of reduced LAIR1 expression in childhood severe malarial anaemia: Implications for leukocyte inhibitory signalling

Angela O. Achieng, Bernard Guyah, Qiuying Cheng et al. · EBioMedicine · 2019 · 20 citations · Full text

Life Sciences, Genetics, Immunology +17

Integrated OMICS platforms identify LAIR1 genetic variants as novel predictors of cross-sectional and longitudinal susceptibility to severe malaria and all-cause mortality in Kenyan children

Angela O. Achieng, Nicolas Hengartner, Evans Raballah et al. · EBioMedicine · 2019 · 19 citations · Full text

Life Sciences, Genetics, Infectious Diseases +17